VISA Inc. Cl A (V) Financials Nov 14, 2014, 7:08

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
VISA Inc. Cl A (V) Financials Nov 14, 2014, 7:08 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for VISA Inc. Cl A


Fiscal year is October-September. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 8.07B 9.19B 10.42B 11.78B 12.7B
Cost of Goods Sold (COGS) incl. D&A 1.91B 2.1B 2.47B 2.8B 2.82B
COGS excluding D&A 1.65B 1.82B 2.14B 2.4B 2.38B
Depreciation & Amortization Expense 265M 288M 333M 397M 435M
Depreciation 265M 225M 265M 328M -
Amortization of Intangibles - 63M 68M 69M -
Gross Income 6.15B 7.08B 7.95B 8.98B 9.89B
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 1.61B 1.62B 1.71B 1.74B 1.74B
Research & Development 0 0 0 0 -
Other SG&A 1.61B 1.62B 1.71B 1.74B 1.74B
Other Operating Expense 0 0 0 0 0
Unusual Expense (42M) (110M) 4.1B 14M 453M
EBIT after Unusual Expense 42M 110M (4.1B) (14M) (453M)
Non Operating Income/Expense 102M 99M 19M 2M 27M
Non-Operating Interest Income 26M 16M 46M 27M -
Equity in Affiliates (Pretax) (4M) - - - -
Interest Expense 72M 32M 0 - -
Gross Interest Expense 72M 32M 0 - -
Interest Capitalized 0 0 0 0 -
Pretax Income 4.64B 5.66B 2.21B 7.26B 7.72B
Income Tax 1.67B 2.01B 65M 2.28B 2.29B
Income Tax - Current Domestic 1.35B 1.68B 1.54B 510M -
Income Tax - Current Foreign 76M 168M 214M 239M -
Income Tax - Deferred Domestic 244M 158M (1.69B) 1.52B -
Income Tax - Deferred Foreign 5M 8M 1M 13M -
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 0 0 0 -
Consolidated Net Income 2.96B 3.65B 2.14B 4.98B 5.44B
Minority Interest Expense (2M) (4M) (2M) 0 -
Net Income 2.97B 3.65B 2.14B 4.98B 5.44B
Extraordinaries & Discontinued Operations 0 0 0 0 -
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 -
Cumulative Effect - Accounting Chg 0 0 0 0 -
Discontinued Operations 0 0 0 0 -
Net Income After Extraordinaries 2.97B 3.65B 2.14B 4.98B 5.44B
Preferred Dividends 0 0 0 0 -
Net Income Available to Common 2.97B 3.65B 2.14B 4.98B 5.44B
EPS (Basic) 4.06 - 3.21 7.65 7.07
Basic Shares Outstanding 729.98M - 668.05M 651.05M 769M
EPS (Diluted) 4.04 - 3.19 7.62 6.03
Diluted Shares Outstanding 986.98M - 822.05M 787.05M 902M
EBITDA 4.81B 5.75B 6.57B 7.64B 8.59B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading